MacroGenics, Inc.
MGNX
$1.40
-$0.02-1.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 127.63M | 165.49M | 154.05M | 149.96M | 141.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 127.63M | 165.49M | 154.05M | 149.96M | 141.33M |
| Cost of Revenue | 183.47M | 181.59M | 186.45M | 189.49M | 192.63M |
| Gross Profit | -55.85M | -16.09M | -32.40M | -39.53M | -51.30M |
| SG&A Expenses | 57.74M | 61.93M | 67.06M | 71.05M | 55.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 241.21M | 243.52M | 253.50M | 260.54M | 248.42M |
| Operating Income | -113.58M | -78.03M | -99.45M | -110.58M | -107.09M |
| Income Before Tax | -74.84M | -35.35M | -54.87M | -66.02M | -97.62M |
| Income Tax Expenses | 1.05M | 1.05M | 944.00K | 944.00K | -- |
| Earnings from Continuing Operations | -75.89 | -36.40 | -55.81 | -66.97 | -97.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.89M | -36.40M | -55.81M | -66.97M | -97.62M |
| EBIT | -113.58M | -78.03M | -99.45M | -110.58M | -107.09M |
| EBITDA | -106.06M | -70.46M | -91.98M | -103.04M | -99.71M |
| EPS Basic | -1.21 | -0.57 | -0.89 | -1.07 | -1.57 |
| Normalized Basic EPS | -1.10 | -0.71 | -0.91 | -1.02 | -0.98 |
| EPS Diluted | -1.21 | -0.58 | -0.89 | -1.08 | -1.58 |
| Normalized Diluted EPS | -1.10 | -0.71 | -0.91 | -1.02 | -0.98 |
| Average Basic Shares Outstanding | 252.12M | 251.63M | 251.16M | 250.48M | 249.74M |
| Average Diluted Shares Outstanding | 252.17M | 251.75M | 251.28M | 250.60M | 249.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |